Ahrens Investment Partners’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$198K Sell
4,855
-628
-11% -$27.1K 0.1% 144
2022
Q4
$281K Sell
5,483
-970
-15% -$46.5K 0.13% 128
2022
Q3
$282K Buy
6,453
+27
+0.4% +$1.31K 0.15% 115
2022
Q2
$337K Sell
6,426
-474
-7% -$24.2K 0.15% 112
2022
Q1
$357K Sell
6,900
-78
-1% -$4.05K 0.11% 131
2021
Q4
$412K Buy
6,978
+19
+0.3% +$941 0.18% 114
2021
Q3
$299K Buy
6,959
+1,134
+19% +$50.2K 0.14% 149
2021
Q2
$228K Buy
5,825
+16
+0.3% +$622 0.11% 203
2021
Q1
$210K Sell
5,809
-201
-3% -$7.14K 0.11% 186
2020
Q4
$221K Sell
6,010
-2,073
-26% -$76K 0.12% 158
2020
Q3
$281K Sell
8,083
-4,422
-35% -$155K 0.19% 118
2020
Q2
$388K Buy
+12,505
New +$425K 0.24% 87
2019
Q3
Sell
-8,324
Closed -$342K 173
2019
Q2
$342K Buy
8,324
+10
+0.1% +$397 0.16% 93
2019
Q1
$335K Sell
8,314
-3,113
-27% -$125K 0.15% 97
2018
Q4
$473K Sell
11,427
-1,048
-8% -$43.5K 0.22% 76
2018
Q3
$522K Buy
12,475
+741
+6% +$28.5K 0.2% 82
2018
Q2
$404K Buy
+11,734
New +$401K 0.17% 85
2017
Q4
Sell
-6,009
Closed -$204K 168
2017
Q3
$204K Buy
+6,009
New +$193K 0.09% 141

Other funds holding PFE

Ahrens Investment Partners's PFE Position: Q1 2023 in Review

Ahrens Investment Partners reduced its Pfizer (PFE) stake by 11% in Q1 2023, selling an estimated $27.1K and leaving 4,855 shares worth $198K. The position accounts for 0.1% of the portfolio, ranked #144.

Ahrens Investment Partners first reported a position in PFE in Q3 2017 and has held it in 18 quarters since. The position peaked at $522K in Q3 2018. 3,102 funds tracked by Wall St. Rank hold PFE as of Q1 2023.

  • Ahrens Investment Partners held 4,855 shares of Pfizer worth $198K as of Q1 2023.
  • Ahrens Investment Partners sold 628 Pfizer shares in Q1 2023, an estimated $27.1K.
  • Pfizer made up 0.1% of Ahrens Investment Partners's portfolio in Q1 2023, its #144 holding.
  • Ahrens Investment Partners first reported a position in Pfizer in Q3 2017 and has held it in 18 quarters since.
  • Ahrens Investment Partners's Pfizer position peaked at $522K in Q3 2018.
  • 3,102 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.

Based on Ahrens Investment Partners's 13F filing for Q1 2023, filed 24 Apr 2023.